article thumbnail

COVID ‘Compromise’ on International IP Underscores Need for New Approach

Bill of Health

It only narrowly modifies compulsory licenses of patents covering COVID vaccines. Moreover, it imposes additional restrictions on use of compulsory licenses. Moreover, Brazil’s new compulsory license law models another critical feature that domestic laws should have – a way around data exclusivity.

COVID-19 309
article thumbnail

Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics

Bill of Health

Consider, for instance, the case of COVID-19 vaccines. Even those relying on a new type of vaccine technology, such as mRNA vaccines , resulted from well over a decade of R&D in mRNA vaccinology and used vaccine components that were developed well before the COVID-19 pandemic began.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

Legally speaking, patent pledges are comparable to the open source software licenses that underlie much of the world’s technology infrastructure and the Creative Commons licenses that make billions of online images, videos and other content freely available (both discussed here ). Tesla and Toyota) to software (e.g,

article thumbnail

Reclaiming Global Public Health

Bill of Health

Consider the United States, for example, which made the unprecedented move to leave the World Health Organization (WHO) during the pandemic. Around the same time, it poured billions of dollars to accelerate vaccine development, without obtaining a single contractual commitment to protect global access.

article thumbnail

Biden Administration Unveils Long-Awaited COVID-19 Rules For Large Employers and Healthcare Workers

Health Law RX

An employee is considered “fully vaccinated” two weeks after completing primary vaccination with a COVID-19 vaccine with, if applicable, at least the minimum interval between doses as recommended by the CDC, World Health Organization (“WHO”), or if administered as a part of a clinical trial.